Improvements in mood symptoms, cognitive symptoms and functioning in outpatients with mdd in greece treated with vortioxetine: A patient-rated evaluation
Introduction Functional recovery is the contemporary treatment goal in Major Depressive Disorder (MDD). Although consistency among physician and patient expectations may influence the therapeutic result (Demyttenaere K et al, 2011), patients’ perceptions are not always fully captured. Vortioxetine...
Main Authors: | A. Galanopoulos, E. Tsiolka, P. Ntounas, D. Mpelimpasakis, D. Karakoutas, N. Sidiropoulos, I. Mpougiouklis, K. Kyziridis, E. Papalexi |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2021-04-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933821008956/type/journal_article |
Similar Items
-
The impact of dose on the real-world effectiveness of vortioxetine in outpatients with mdd in greece
by: E. Papalexi, et al.
Published: (2021-04-01) -
Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects
by: Eugenia Papalexi, et al.
Published: (2022-08-01) -
Efficacy of vortioxetine monotherapy compared with combined therapy vortioxetine and olanzapine in the treatment of major depression – first results
by: Oppa M., et al.
Published: (2017-09-01) -
Withdrawal Symptoms Following Discontinuation of Vortioxetine—Retrospective Chart Review
by: Marcin Siwek, et al.
Published: (2021-05-01) -
Case Report: Vortioxetine in the Treatment of Depressive Symptoms in Patients With Epilepsy—Case Series
by: Marcin Siwek, et al.
Published: (2022-03-01)